TERM SHEETLease Agreement • February 10th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This term sheet (the “Offer”) sets out and confirms the agreement between MaRS Discovery District (“Landlord”) and NPS Pharmaceuticals, Inc. (“Tenant”) with respect to the lease of space within part of the Building municipally known as 101 College Street (South Tower) in the City of Toronto, Province of Ontario (the “Building”), on the terms and conditions hereinafter set forth.
AGREEMENT PROVIDING SPECIFIED BENEFITS FOLLOWING TERMINATION OF EMPLOYMENT INCIDENT TO A MERGER, ACQUISITION OR OTHER CHANGE OF CONTROL OR TO SOME OTHER STRATEGIC CORPORATE EVENT OR OTHER EVENTSeverance Agreement • February 10th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Agreement is entered into on the Effective Date shown above (the “Effective Date”) between NPS Pharmaceuticals, Inc., a Delaware corporation, for itself and its subsidiaries (the “Company”) and the Executive identified above (“Executive”), an employee of the Company.
UNIVERSITY OF UTAH RESEARCH PARK MASTER FORM LEASE LEASE AGREEMENTLease Agreement • February 10th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS LEASE AGREEMENT (this “Lease”) is entered into this 10th day of December, 2003, by and between the UNIVERSITY OF UTAH, a body politic and corporate, hereinafter referred to as the “Lessor”, and NPS PHARMACEUTICALS, INC., a Delaware Corporation, hereinafter referred to as the “Lessee”.
ContractSublease Agreement • February 10th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
AGREEMENT OF SUBLEASE, dated as of the day of November, 2003, by and between HARRISON & STAR, INC. D/B/A HYPHEN SOLUTIONS, having offices c/o Omnicom Group Inc., 437 Madison Avenue, New York, New York 10022 (“Sublessor”), and NPS PHARMACEUTICALS, INC., a Delaware corporation, having offices at 420 Chipeta Way, Salt Lake City, Utah 84108 (“Sublessee”).
